Open House Drug Discount Agreements for Therapy Allergens Tender

• Country: Germany
• Summary: Open House Drug Discount Agreements for Therapy Allergens with the Finished Drug Names Grazax(R) and Alk-Depot(R), Atc V01aa02
• DET Ref No: 93903565
• Deadline: 05 Dec 2025
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 765620-2023
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• This is not an open procedure, but rather a so-called open-house model! The form for the open procedure is only used because there is no form for the open-house model. Contracts concluded in the open-house model are not applicable due to a lack of selection decisionoath does not comply with public procurement law. The use of this form does not involve subjection to procurement regulations. AOK Bayern intends to enter into non-exclusive discount agreements on the active ingredient therapy allergens with all interested pharmaceutical companieswith the finished medicinal product name Grazax(R) and ALK-depot(R), ATC V01AA02, in accordance with Section 130a Paragraph 8 SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility requirements listed below to take out identical and non-individual contractsnegotiable discount agreements. The earliest possible start of the contract is February 1st, 2024, all contracts end on January 31st, 2026. A contract can be concluded at any time during this term, but no later than December 5th, 2025. The contracts can be terminated with one month's notice to the end of the monthbe dignified. When a nationwide or state-specific, open-procedure discount agreement for medicines with the active ingredient in question comes into force, the open-house agreements automatically expire for the corresponding term. A contract will be...
• Documents:

 Tender Notice